Lonza Group AG
LONN
Classement en actions
#447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Prix de l'action
$764.04
Capitalisation boursière
$53.36B
Changement (1 jour)
0.96%
Changement (1 an)
8.59%
Pays
CH
Échange Lonza Group AG (LONN)
Catégorie
Healthcare
Ratio P/S pour Lonza Group AG (LONN)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Lonza Group AG, le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Lonza Group AG de 2004 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| 2025 | 5.77 | -0.67% |
| 2024 | 5.80 | 49.68% |
| 2023 | 3.88 | -28.25% |
| 2022 | 5.40 | -48.31% |
| 2021 | 10.46 | 11.37% |
| 2020 | 9.39 | 50.88% |
| 2019 | 6.22 | 81.59% |
| 2018 | 3.43 | -12.81% |
| 2017 | 3.93 | 88.09% |
| 2016 | 2.09 | -0.13% |
| 2015 | 2.09 | 40.40% |
| 2014 | 1.49 | 30.83% |
| 2013 | 1.14 | 70.33% |
| 2012 | 0.67 | -37.18% |
| 2011 | 1.06 | -27.38% |
| 2010 | 1.47 | 6.38% |
| 2009 | 1.38 | -21.31% |
| 2008 | 1.75 | -30.69% |
| 2007 | 2.53 | 0.33% |
| 2006 | 2.52 | 66.67% |
| 2005 | 1.51 | 8.72% |
| 2004 | 1.39 | 0.00% |
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 4.19 | - |
AU
|
|
| 10.44 | - |
NL
|
|
| 4.52 | - |
BE
|
